tiprankstipranks
Trending News
More News >
Biosergen AB (DE:8N1)
FRANKFURT:8N1
Germany Market

Biosergen AB (8N1) Cash flow

Compare
1 Followers

Biosergen AB Cash Flow

DE:8N1's free cash flow for Q4 2024 was kr-725.00K. For the 2024 fiscal year, DE:8N1's free cash flow was decreased by kr15.97M and operating cash flow was kr-725.00K. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
kr -16.63Mkr -32.60Mkr -29.44Mkr -37.75Mkr -4.58M
Investing Cash Flow
kr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Financing Cash Flow
kr 65.36Mkr 5.30Mkr 37.12Mkr 70.59Kkr 0.00
End Cash Position
kr 50.61Mkr 1.88Mkr 29.34Mkr 21.66Mkr 589.00K
Free Cash Flow
kr -16.63Mkr -32.60Mkr -29.44Mkr -37.75Mkr -4.58M
Currency in SEK

Biosergen AB Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis